Phreesia PHR 深 沪
已收盘 02-06 16:00:00 美东时间
12.20
-0.390
-3.10%
华盛通- 最 高12.675
- 今 开12.60
- 成交量 200.51万股
- 最 低 12.06
- 昨 收 12.59
- 总市值 7.36亿
- 52周最高 32.76
- 市盈率 静 --
- 换手率 3.33%
- 52周最低 12.06
- 委 比 -81.67%
- 总股本 6028.70万
- 历史最高 81.592
- 量 比 0.90
- 振 幅 4.88%
- 历史最低 12.05
- 每 手 1
- 风险率 4.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Phreesia Inc. Issues Amended 8-K Following AccessOne Acquisition
Phreesia Inc. Issues Amended 8-K Following AccessOne Acquisition Phreesia Inc. issued an amendment to its current report, disclosing that on November 12, 2025, it acquired 100% of the equity of AccessOne Parent Holdings, Inc. for a base purchase price of $160 million in cash. The acquisition also in
01-29 06:30
美股大行评级 | 英特尔绩后获多家大行上调目标价；理想汽车、Mobileye、Meta、微软、甲骨文等遭下调目标价
今日重点评级关注：RBC Capital：维持Compass Pathways"跑赢大市"评级，目标价从16美元升至21美元；RBC Capital：维持GH Research"跑赢大市"评级，目标价从33美元升至40美元
01-26 14:32
DA Davidson Maintains Buy on Phreesia, Lowers Price Target to $30
DA Davidson analyst Clark Wright maintains Phreesia (NYSE:PHR) with a Buy and lowers the price target from $35 to $30.
01-23 23:52
U.S. RESEARCH ROUNDUP-Cencora, Crocs, Teledyne Technologies
U.S. RESEARCH ROUNDUP-Cencora, Crocs, Teledyne Technologies Jan 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cencora, Crocs and Teledyne Technologies, on Thursday. HIGHLIGHTS * Cencora COR.N : Jefferies raises to b
01-22 15:17
美股大行评级 | 瑞穗上调英伟达、谷歌、美光科技、SanDisk多家科技股目标价；中金首予诺和诺德"跑赢大市"评级，目标价73.5美元
今日重点评级关注：Needham：维持Cartesian Therapeutics"买入"评级，目标价从40美元升至42美元；Piper Sandler：维持Acrivon Therapeutics"超配"评级，目标价从6美元升至8美元
01-12 14:09
Duolingo Announces CFO Transition
<p>Duolingo appoints Gillian Munson as CFO, effective February 23, 2026, succeeding Matt Skaruppa, who will transition to an advisory role. Munson, a Board member and Chair of the Audit Committee since 2019, brings extensive financial leadership experience, including CFO roles at Vimeo, Iora Health, and XO Group. Skaruppa, departing after nearly six years, oversaw Duolingo's IPO and six years of financial growth. The company also reported Q4 2025...
01-12 11:45
Citigroup Maintains Buy on Phreesia, Lowers Price Target to $25
Citigroup analyst Daniel Grosslight maintains Phreesia (NYSE:PHR) with a Buy and lowers the price target from $29 to $25.
01-10 00:02
Wells Fargo Initiates Coverage On Phreesia with Overweight Rating, Announces Price Target of $30
Wells Fargo analyst Stan Berenshteyn initiates coverage on Phreesia (NYSE:PHR) with a Overweight rating and announces Price Target of $30.
01-09 21:47
美股大行评级 | 潜在涨幅263.64%！Milestone Pharmaceuticals获富国银行升目标价至8美元，维持"超配"评级
今日重点评级关注：富国银行：维持Milestone Pharmaceuticals"超配"评级，目标价从4美元升至8美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从31美元升至33美元
2025-12-17 10:46
美股大行评级 | 超配！大摩上调回声星通信评级；汽车地带、CBRL、金宝汤、家得宝等遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从8美元升至8.25美元；Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12.5美元升至13美元
2025-12-11 10:33
